Strides Pharma Science

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue572.06528.71647.26594.04633.51
Expenses578.91519.89594.42590.48619.06
EBITDA57.9074.34120.4373.8686.57
EBIT34.8847.9999.5551.9564.58
Profit Before Tax-6.853.5252.773.5714.43
Net Profit-6.752.5453.662.4015.31
Financial Ratios
Operating Profit Margin10.48%13.28%19.49%12.61%14.19%
Net Profit Margin-1.22%1.32%8.70%0.41%2.51%
Earning Per Share (Diluted)-0.750.285.830.261.66
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ